Follow The Filings

XNCR Xencor

Xencor earnings company data as of 10:00 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by XNCR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XNCR insider trades
  • None no insider bought on the open market
  • $3.5M sold by 4 insiders outside a trading plan
  • $379K sold by 5 insiders under 10b5-1 plans
  1. Ellen Feigal Director
    Planned sale
    $89K 6,843 shares at $13.06 36% of stake
    Traded Jun 18 Filed Jun 22
    ↗
  2. Kurt A Gustafson Director
    Planned sale
    $67K 5,474 shares at $12.31 27% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  3. Alan Bruce Montgomery Director
    Planned sale
    $62K 5,064 shares at $12.31 25% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  4. Kevin Charles Gorman Director
    Planned sale
    $93K 7,527 shares at $12.31 40% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  5. Bart Jan Cornelissen CFO
    Sale
    $43K 3,499 shares at $12.29 4.4% of stake
    Traded Apr 10 Filed Apr 13
    ↗
  6. Bart Jan Cornelissen CFO
    Sale
    $28K 2,517 shares at $11.25 3.1% of stake
    Traded Mar 5 Filed Mar 9
    ↗
  7. Celia Eckert SVP, General Counsel
    Sale
    $56K 5,011 shares at $11.17 6.1% of stake
    Traded Mar 5–6 Filed Mar 9
    ↗
  8. John R Desjarlais Sr. Vice President & Cso
    Sale
    $74K 6,620 shares at $11.16 2.4% of stake
    Traded Mar 5–6 Filed Mar 9
    ↗
  9. Bassil I Dahiyat CEO
    Sale
    $240K 21,476 shares at $11.18 3.8% of stake
    Traded Mar 5–6 Filed Mar 9
    ↗
  10. Celia Eckert SVP, General Counsel
    Sale
    $18K 1,492 shares at $11.90 1.8% of stake
    Traded Mar 3 Filed Mar 4
    ↗
  11. John R Desjarlais Sr. Vice President & Cso
    Sale
    $32K 2,663 shares at $11.90 1% of stake
    Traded Mar 3 Filed Mar 4
    ↗
  12. Bassil I Dahiyat CEO
    Sale
    $80K 6,758 shares at $11.90 1.2% of stake
    Traded Mar 3 Filed Mar 4
    ↗
  13. John R Desjarlais Sr. Vice President & Cso
    Sale
    $1.2M 73,367 shares at $15.72 24% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗
  14. Bassil I Dahiyat CEO
    Sale
    $1.8M 114,377 shares at $15.71 20% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants and 5 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 5.02,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.02 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.